Cramer: Allergan Is the New Pharma Growth Stock
Jim Cramer compares Allergan's growth to other pharma stocks.
Jim Cramer declared Allergan (AGN) - Get Report , not Bristol-Myers Squibb (BMY) - Get Report , the new pharma growth stock. Cramer listed companies that are also lagging behind Allergan, like Merck (MRK) - Get Report , Pfizer (PFE) - Get Report , Glaxo Smithkline (GLAXF) and AstraZeneca (AZN) - Get Report .
Cramer went on to say that Eli Lily (LLY) - Get Report comes close, but remarked that Celgene (CELG) - Get Report and Biogen (BIIB) - Get Report haven't grown as fast as Allergan.
Allergan is a holding in Jim Cramer's Action Alerts PLUS Charitable Trust Portfolio
. Want to be alerted before Cramer buys or sells AGN?
